Home › Sickle Cell Disease › New York › Queens
Sickle Cell Disease clinical trials in Queens, NY
4 studies for Sickle Cell Disease are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
- NYC Health + Hospitals/Queens, Jamaica · 2 mi away
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RecruitingPhase 3
- Cohen Children's Medical Ctr, Queens
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RecruitingObservational study
- Cohen's Children Hospital (NT-DMT), Queens
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi away
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Washington, DC21 studies
- Atlanta, GA20 studies
- Memphis, TN19 studies
- Chicago, IL18 studies
- New York City, NY16 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- Houston, TX12 studies
- Boston, MA12 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Cincinnati, OH10 studies
Other studies in Queens
- Breast Cancer67 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer28 studies
- Prostate Cancer27 studies
- Endometrial Cancer26 studies
- Cancer (all types)25 studies
- Pancreatic Cancer23 studies
- Lung Cancer22 studies
- Multiple Myeloma19 studies
- Acute Myeloid Leukemia19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.